Interaction of the Calcium Channel Activating ³H-Bay K 8644 and Inhibiting ³H-Verapamil with Specific Receptor Sites on Cultured Beating Myocardial Cells

References

• Bellemann P., Ferry D., Lübbecke F., Glossmann H. 3H-Nitrendipine, a potent calcium antagonist binds with high affinity to cardiac membranes. Arzneim.-Forsch./Drug Res. 1981; 31: 2064–2067
   PubMed Web of Science ®Google Scholar
• Bolger G. T., Gengo P. J., Luchowski E. M., Siegel H., Triggle D. J., Janis R. A. High affinity binding of a calcium channel antagonist to smooth and cardiac muscle. Biochem. Biophys. Res. Commun. 1982; 104: 1604–1609
   PubMed Web of Science ®Google Scholar
• Bellemann P., Schade A. Receptors for dihydropyridine calcium channel antagonists. Cell Surface Receptors, P. G. Strange. W. Sussex, Horwood, ChichesterEngland 1983; 101–109
   Google Scholar
• Bellemann P., Ferry D., Lübbecke F., Glossmann H. 3H-Nimodipine and 3H-nitrendipine as tools to identify directly the site of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Arzneim.-Forsch./Drug Res. 1982; 32: 361–363
   PubMed Web of Science ®Google Scholar
• Bellemann P. Observations on receptor sites for dihydropyridines. Investigation of Membrane-Located Receptors, E. Reid, G. M. W. Cook, J. D. Morré. Plenum Press, New York 1984; 513–518
   Google Scholar
• Janis R. A., Maurer S. C., Scamiento J. C., Bolger G. T., Triggle D. J. Binding of 3H-nimodipine to cardiac and smooth muscle membranes. Eur. J. Pharmacol. 1982; 82: 191–194
   PubMed Web of Science ®Google Scholar
• Holck M., Thorens S., Haeusler G. Characterization of 3H-nifedipine binding sites in rabbit myocardium. Eur. J. Pharmacol. 1982; 85: 305–315
   PubMed Web of Science ®Google Scholar
• Bellemann P., Schade A., Towart R. Dihydropyridine receptor in rat brain labeled with 3H-nimodipine. Proc. Natl. Acad. Sci. USA 1983; 80: 2356–2360
   PubMed Web of Science ®Google Scholar
• Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. 1977; 17: 147–166
   Web of Science ®Google Scholar
• Schramm M., Thomas G., Towart R., Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature 1983; 303: 535–537
   PubMed Web of Science ®Google Scholar
• Bellemann P. Amino acid and rubidium ion uptake in monolayer cultures of hepatocytes from neonatal rats. Biochem. J. 1981; 198: 475–483
   PubMed Web of Science ®Google Scholar
• Reuter H. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 1983; 301: 569–574
   PubMed Web of Science ®Google Scholar
• Bellemann P. Primary cultures of liver parenchymal cells and kidney cortical tubules as a useful new model for biochemical pharmacology and experimental toxicology: Studies in vitro on hepatic membrane transport, induction of liver enzymes, and adaptive changes in renal cortical enzymes. Arch. Toxicol. 1980; 44: 63–84
   PubMed Web of Science ®Google Scholar
• Bellemann P. Binding properties of a novel calcium channel activating dihydropyridine in monolayer cultures of beating myocytes. FEBS-Lett. 1984; 167: 88–92
   PubMed Web of Science ®Google Scholar
• Moscona A. A. Rotation-mediated histogenetic aggregation of dissociated cells: a quantifiable approach to cell interaction in vitro. Exp. Cell. Res. 1961; 22: 455–474
   PubMed Web of Science ®Google Scholar
• Tarr M. Two inward currents in frog atrial muscle. J. Gen. Physiol. 1971; 58: 523–543
   PubMed Web of Science ®Google Scholar
• Goshima K. Initiation of beating in quiescent myocardial cells by norepinephrine, by contact with beating cells and by electrical stimulation of adjacent FL cells. Exp. Cell. Res. 1974; 84: 223–234
   PubMed Web of Science ®Google Scholar
• Reuter H., Stevens C. F., Tsien R. W., Yellen G. Properties of single calcium channels in cardiac cell culture. Nature 1982; 297: 501–504
   PubMed Web of Science ®Google Scholar
• Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 1976; 72: 248–253
   PubMed Web of Science ®Google Scholar
• Bennet J. P., Jr. Methods in binding studies. Neurotransmilter Receptor Binding, H. I. Yamamura, S. J. Enna, M. J. Kuhar. Raven Press, New York 1978; 57–90
   Google Scholar
• Fields I. Z., Reisine R. T., Yamamura H. I. Biochemical demonstration of dopaminergic receptors in rat and human brain using 3H-spiroperidol. Brain Res. 1977; 136: 578–584
   PubMed Web of Science ®Google Scholar
• Yamamura H. I., Snyder S. H. Muscarinic cholinergic receptor binding in the longitudinal muscle of the guinea pig ileum with 3H-quinuclidinylbenzilate. Molec. Pharmacol. 1974; 10: 861–867
   Web of Science ®Google Scholar
• Greengrass P., Bremmer R. Binding characteristics of 3H-prazosin to rat brain-adrenergic receptors. Eur. J. Pharmacol. 1979; 55: 323–326
   PubMed Web of Science ®Google Scholar
• U'Prichard D. C., Greenberg D. A., Snyder S. H. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. Molec. Pharmacol. 1977; 13: 454–473
   PubMed Web of Science ®Google Scholar
• Bylund D. B., Snyder S. H. Beta adrenergic receptor binding in membrane preparations from mammalian brain. Molec. Pharmacol. 1976; 12: 568–580
   PubMed Web of Science ®Google Scholar
• Bennet J. P., Jr, Snyder S. H. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Molec. Pharmacol. 1976; 12: 373–389
   PubMed Web of Science ®Google Scholar
• Burkard W. P. Histamine H2-receptor binding with 3H-cimetidine in brain. Eur. J. Pharmacol. 1978; 50: 449–450
   PubMed Web of Science ®Google Scholar
• Snodgrass R. S. Use of 3H-muscimol for GABA receptor studies. Nature 1978; 273: 392–394
   PubMed Web of Science ®Google Scholar
• Braestrup C., Squires R. F. Specific benzodiazepine receptors in rat brain characterized by high-affinity 3H-diazepam binding. Proc. Natl. Acad. Sci. USA 1977; 74: 3805–3809
   PubMed Web of Science ®Google Scholar
• Pert C. B., Snyder S. H. Opiate receptor binding: enhancement by opiate administration in vivo. Biochem. Pharmacol. 1976; 25: 847–857
   PubMed Web of Science ®Google Scholar
• Ehlert F. J., Roeske W. R., Itoga E., Yamamura H. J. The binding of 3H-nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. Life Sci. 1982; 30: 2191–2202
   PubMed Web of Science ®Google Scholar
• Hulthén U. L., Landmann R., Bürgisser E., Bühler F. R. High-affinity binding sites for 3H-verapamil in cardiac membranes. J. Cardiovasc. Pharmacol. 1982; 4: S291–S293
   Web of Science ®Google Scholar
• Truog Brunner A. G.H., Criscione L., Fallert M., Kuhnis H., Meier M., Rogg H. CGP 28392, a dihydropyridine Ca2+ entry stimulator. Calcium in Biological Systems, R. P. Rubin, G. B. Weiss, J. W. Putney, Jr. Plenum Press, New York 1984, In press
   Google Scholar
• Kokubun S., Reuter H. Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells. Proc. Natl. Acad. Sci. USA 1984; 81, in press
   PubMed Web of Science ®Google Scholar
• Meyer H., Kazda S., Bellemann P. Calcium antagonists, new opportunities. Annu. Repts. Med. Chem. 1983; 18: 79–88
   Web of Science ®Google Scholar